使用可穿戴设备测量的体力活动作为晚期肺癌患者体能状态的替代指标
这项单机构前瞻性观察研究纳入119例计划接受全身治疗的晚期肺癌门诊患者,佩戴可穿戴设备amuelink(Sony)最多14天测量体力活动。平均步行距离(MDW)对ECOG PS≥2的分类AUC为0.818(95%CI 0.703-0.934),对6个月生存的AUC为0.806(95%CI 0.694-0.918),生存曲线基于MDW阈值显著分离(HR 0.17;95%CI 0.05-0.57)。作者认为MDW与ECOG PS相关,可能作为健康状态预测指标补充主观ECOG PS评估,需进一步研究确认其预后价值。
要点
- 可穿戴设备测量的平均步行距离对ECOG PS≥2分类的AUC为0.818(95%CI 0.703-0.934)。
- 平均步行距离对6个月生存的AUC为0.806(95%CI 0.694-0.918)。
- 基于平均步行距离阈值的生存曲线显著分离,HR为0.17(95%CI 0.05-0.57)。
核心结论
- 该队列研究提示,可穿戴设备测量的平均步行距离与ECOG PS相关,可能作为健康状态预测指标与ECOG PS分类并列使用。
- 研究显示客观测量的体力活动有潜力补充晚期肺癌患者主观ECOG PS评估。
- 需进一步研究确认体力活动测量的预后价值。
研究设计与样本
- 单机构前瞻性观察研究,在日本三重县松阪市立医院招募119例计划接受全身治疗的晚期肺癌门诊患者。
- 参与者佩戴可穿戴设备amuelink(Sony)最多14天,测量代谢当量任务、步行距离和步数等体力活动。
- 入组时评估ECOG PS,入组时间为2021年12月至2022年8月。
- 主要终点为使用体力活动测量对ECOG PS≥2分类的曲线下面积(AUC)。
主要发现
- 119例患者中位(范围)年龄72(32-88)岁,男性71例(59.7%)。
- 平均步行距离对ECOG PS≥2分类的诊断价值最高,AUC为0.818(95%CI 0.703-0.934)。
- 平均步行距离与6个月生存相关,AUC为0.806(95%CI 0.694-0.918)。
- 生存曲线基于平均步行距离阈值显著分离,风险比为0.17(95%CI 0.05-0.57)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需进一步研究确认体力活动测量的预后价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The Eastern Cooperative Oncology Group Performance Status (ECOG PS) is extensively used to guide treatment decisions in patients with advanced lung cancer. However, its assessment is subjective, potentially leading to discordance among observers. OBJECTIVE: To investigate the association between measured physical activity and ECOG PS, as well as the potential prognostic value of physical activity measurements in patients with advanced lung cancer. DESIGN, SETTING, AND PARTICIPANTS: This single-institution, prospective observational study enrolled 119 patients with advanced lung cancer scheduled to receive systemic therapy as outpatients at Matsusaka Municipal Hospital in Mie, Japan. Participants wore the wearable device amuelink (Sony) for up to 14 days to measure physical activity, including metabolic equivalent tasks, distance walked, and number of steps taken. ECOG PS was assessed at enrollment, which took place from December 2021 to August 2022. MAIN OUTCOMES AND MEASURES: The primary end point was estimating the area under the curve (AUC) for classification into ECOG PS of 2 or higher using physical activity measurements. An analysis of the association with survival was also conducted. RESULTS: Among the 119 patients (median [range] age, 72 (32-88) years; 71 [59.7%] male), mean distance walked (MDW) had the highest diagnostic value for classifying an ECOG PS of 2 or greater, with an AUC of 0.818 (95% CI, 0.703-0.934). Moreover, MDW was also associated with 6-month survival, with an AUC of 0.806 (95% CI, 0.694-0.918). Survival curves significantly diverged based on the MDW threshold, indicating a potential association with survival outcome (hazard ratio, 0.17; 95% CI, 0.05-0.57). CONCLUSIONS AND RELEVANCE: The cohort study suggests that MDW, as measured by a wearable device, was associated with ECOG PS and may serve as a predictor of health status alongside ECOG PS categories. It demonstrates the potential of objectively measured physical activity in complementing subjective ECOG PS assessments in patients with advanced lung cancer. Further research is needed to confirm the prognostic value of physical activity measurements.
引用
- Ito K, Suzuki Y, Sakaguchi T, et al. Physical Activity Using a Wearable Device as an Alternative to Performance Status in Patients With Advanced Lung Cancer. JAMA Oncol. 2024. PMID: 38546663. doi:10.1001/jamaoncol.2024.0023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。